Emilia Mazzuca

TL;DR: A narrative review of recent studies on OSA patients, with special attention to cardiovascular and cerebrovascular comorbidities, the metabolic syndrome and type 2 diabetes, asthma, COPD and cancer, to provide an update on recent studies.

TL;DR: The visceral adiposity index was a good marker of metabolic syndrome, but not of obstructive sleep apnea, and changed little in patients without metabolic syndrome; conversely, waist circumference was the only correlate of apnea–hypopnea index in men and women with metabolic syndrome.

TL;DR: Intense endurance exercise causes mild epithelial injury and inflammation in the airways, but does not appear to exert detrimental effects on respiratory health or bronchial reactivity in recreational/non-elite athletes.

TL;DR: Ultrasound liver assessment is feasible in most OSA patients, and CPAP treatment may positively affect liver steatosis, which is associated with biopsy-proven liver damage in morbid obesity.

TL;DR: Sleep disturbances due to COPD symptoms are associated with heterogeneity of airway constriction, possibly reflecting peripheral airway dysfunction.